Jharkhand: Health Worker Dies Just a Day After COVID-19 Vaccination

By: Sashwata Saha
03 Feb 2021 11:55:01 PM Jharkhand

A health worker has died 36 hours after being administered COVID vaccine in Jharkhand, officials said to news agency PTI on Wednesday.


The health worker, identified as Mannu Pahan, was administered the Covishield vaccine at his workplace a private medical establishment called Medanta Hospital in Ranchi on Monday and he died on Tuesday night. The institute's CEO Dr Pankaj Sahni confirmed the same on local television.


Though 52-year-old Pahan did not have comorbidities, the cause of his death is being investigated. After being administered the vaccine, Pahan returned to his village in Ormanjhi a two-hour drive from Ranchi and even came to work on February 2, the morning of his death. He fell ill in his village on the same night and died while being taken to the hospital. 


“Post-mortem examination will be conducted on the body by a medical board at state-run Rajendra Institute of Medical Sciences to ascertain the cause of his death,” Dr Ajit Prasad, nodal officer for the COVID-19 vaccination programme in the state, said to PTI


He added that a total of 151 health workers including Pahan had been vaccinated at Medanta Hospital on February 1. Nine others received the vaccine from the same vial from which Pahan was vaccinated and none of them has reported any inconvenience yet. 


“So, it is yet to be confirmed whether he died due to the vaccine,” Prasad said.


So far, in the 18 days since the start of India’s vaccine drive, 14 health workers have died after receiving their dosage. It must be remembered that the health workers are the first demographic group in the country to be receiving coronavirus vaccines. 


The deaths have been reported from Uttar Pradesh, Karnataka, Andhra Pradesh, Rajasthan, Telangana, Gurugram, Odisha and West Bengal. All the men and women who died were all between 27 and 56 years old. The deaths took place between 24 hours and five days of taking the vaccines and all have been ascribed to cardiovascular problems or “brain stroke.”


The vaccine taken in each case was Covishield.


Covishield is the Serum Institute of India’s version of the AZD1222 COVID-19 vaccine developed by the University of Oxford and British-Swedish pharmaceutical giant AstraZeneca. Considering its six-month shelf life and the ability to be handled at normal temperatures, it was accepted by the Union health ministry for use in emergency situations and is now one of the two vaccines being offered in the country’s vaccine drive. The other being the indigenously developed Covaxin,


Post Comments